Clinical Trial Update: Varenicline for Smoking Cessation in Hospitalized Patients With Psychiatric Disorders [Phase 4]

View source ↗

Summary

Phase 4 study of varenicline for smoking cessation in hospitalized patients with psychiatric disorders has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychiatric Disorders
• Tobacco Use Disorder

Drugs mentioned

• Varenicline (varenicline)

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Tobacco Use Cessation, Psychiatric Disorders | Phase 4 | Status: WITHDRAWN